Dermatologic findings associated with semaglutide use: A scoping review.

Tran, Megan M; Mirza, Fatima N; Lee, Adrian C; Goldbach, Hayley S; Libby, Tiffany J; Wisco, Oliver J

Tran, Megan M; Mirza, Fatima N; Lee, Adrian C; Goldbach, Hayley S; Libby, Tiffany J; Wisco, Oliver J.

Tran MM; Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Mirza FN; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Lee AC; Brown University, Providence, Rhode Island.
Goldbach HS; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Libby TJ; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Wisco OJ; Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

J Am Acad Dermatol ; 91(1): 166-168, 2024 Jul.

Article en En | MEDLINE | ID: mdl-38554940

Asunto(s)

Péptidos Similares al Glucagón; Hipoglucemiantes; Humanos; Péptidos Similares al Glucagón/efectos adversos; Hipoglucemiantes/efectos adversos; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Erupciones por Medicamentos/etiología

Palabras clave

GLP-1 agonist; adverse events; alopecia; altered skin sensation; cutaneous findings; dermatologic manifestations; diabetes medication; dosage; glucagon-like peptide-1 receptor agonist; obesity medication; scoping review; semaglutide; side effects; skin findings; systematic review; weight loss medication

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos Similares al Glucagón / Hipoglucemiantes Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google